![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 491/147 | (2006.01) |
A61P 19/02 | (2018.01) | ||
C07D 491/048 | (2006.01) | ||
C07D 491/147 | (2013.01) | ||
A61K 31/437 | (2006.01) | ||
C07D 491/048 | (2013.01) | ||
A61P 19/02 | (2006.01) | ||
A61K 31/4155 | (2006.01) | ||
A61K 31/519 | (2006.01) |
(11) | Patento numeris | 3509591 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17858944.6 |
Europos patento paraiškos padavimo data | 2017-09-30 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-07-17 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-17 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2017/054668 |
Data | 2017-09-30 |
(87) | Numeris | WO 2018/067422 |
Data | 2018-04-12 |
(30) | Numeris | Data | Šalis |
201662403660 P | 2016-10-03 | US |
(72) |
LIANG, Congxin , US
|
(73) |
Highlightll Pharmaceutical (Hainan) Co., Ltd. ,
Building A, 5th floor,
Suite A22-21,
Incubator Center of Haikou Hightech
Industrial Development Zone,
Haikou, Hainan, 570000,
CN
|
(54) | NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOF |
NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOF |